Private Capital Group, LLC Alkermes Plc. Transaction History

Private Capital Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$13.31 - $19.41 $692 - $1,009	-52 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$13.06 - $21.24 $679 - $1,104	52 New	52 $1,000
Q3 2019 Nov 13, 2019	SELL	$19.51 - $24.28 $11,237 - $13,985	-576 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$21.47 - $37.33 $12,366 - $21,502	576 New	576 $24,000
Q1 2019 Apr 26, 2019	SELL	$28.4 - $36.49 $9,911 - $12,735	-349 Closed	0 $0
Q4 2018 Jan 28, 2019	SELL	$27.94 - $44.61 $5,755 - $9,189	-206 Reduced 37.12%	349 $10,000
Q3 2018 Oct 31, 2018	SELL	$38.6 - $46.12 $3,474 - $4,150	-90 Reduced 13.95%	555 $23,000
Q2 2018 Aug 09, 2018	SELL	$40.56 - $51.36 $1,297 - $1,643	-32 Reduced 4.73%	645 $26,000
Q1 2018 May 16, 2018	BUY	$53.61 - $67.26 $4,288 - $5,380	80 Added 13.4%	677 $39,000
Q4 2017 May 18, 2018	BUY	$47.69 - $55.39 $24,608 - $28,581	516 Added 637.04%	597 $33,000
Q4 2017 Mar 07, 2018	BUY	$47.69 - $55.39 $3,862 - $4,486	81	81 $2,000

346

183M

209K

89.4K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.6B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Capital Group, LLC with notifications on news.